Update in Pulmonary Medicine
Authors: John E. Heffner
Journal: Annals of Internal Medicine (2006)

Updates21 November 2006Update in Pulmonary MedicineJohn E. Heffner, MDJohn E. Heffner, MDFrom Providence Portland Medical Center and the Oregon Clinic, Portland, Oregon.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-145-10-200611210-00009 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail This Update in Pulmonary Medicine features notable publications in pulmonary medicine from 2005 that cover pneumonia, asthma, chronic obstructive pulmonary disease, pulmonary embolism, lung cancer, and interstitial lung disease. Changes to clinical practice emerging from these articles are shown in the Table .Table. Changes to Practice Emerging from Articles Important to Pulmonologists in 2005* PneumoniaNonadherence to Guidelines Was an Independent Risk Factor for Treatment Failure and Death ...References1. Frías J, Gomis M, Prieto J, Mensa J, Bouza E, García-Rodríguez JA, et al. [Initial empirical antibiotic treatment of community-acquired pneumonia]. Rev Esp Quimioter. 1998;11:255-61. [PMID: 9795313] MedlineGoogle Scholar2. Davies RJ, Traill ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax. 1997;52:416-21. [PMID: 9176531] CrossrefMedlineGoogle Scholar3. Bouros D, Schiza S, Tzanakis N, Chalkiadakis G, Drositis J, Siafakas N. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study. Am J Respir Crit Care Med. 1999;159:37-42. [PMID: 9872815] CrossrefMedlineGoogle Scholar4. Heffner JE. Multicenter trials of treatment for empyema—after all these years [Editorial]. N Engl J Med. 2005;352:926-8. [PMID: 15745984] CrossrefMedlineGoogle Scholar5. Diacon AH, Theron J, Schuurmans MM, Van de Wal BW, Bolliger CT. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Crit Care Med. 2004;170:49-53. [PMID: 15044206] CrossrefMedlineGoogle Scholar6. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. NIH publication no. 02-3659. Bethesda, MD: National Institutes of Health; 2002. Google Scholar7. Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax. 2004;59 Suppl 1 1-232. [PMID: 15041752] MedlineGoogle Scholar8. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163:1256-76. [PMID: 11316667] CrossrefMedlineGoogle Scholar9. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med. 2000;343:1902-9. [PMID: 11136260] CrossrefMedlineGoogle Scholar10. Jarad NA, Wedzicha JA, Burge PS, Calverley PM. An observational study of inhaled corticosteroid withdrawal in stable chronic obstructive pulmonary disease. ISOLDE Study Group. Respir Med. 1999;93:161-6. [PMID: 10464871] CrossrefMedlineGoogle Scholar11. O'Brien A, Russo-Magno P, Karki A, Hiranniramol S, Hardin M, Kaszuba M, et al. Effects of withdrawal of inhaled steroids in men with severe irreversible airflow obstruction. Am J Respir Crit Care Med. 2001;164:365-71. [PMID: 11500334] CrossrefMedlineGoogle Scholar12. van der Valk P, Monninkhof E, van der Palen J, Zielhuis G, van Herwaarden C. Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study. Am J Respir Crit Care Med. 2002;166:1358-63. [PMID: 12406823] CrossrefMedlineGoogle Scholar13. Vincken W, van Noord JA, Greefhorst AP, Bantje TA, Kesten S, Korducki L, et al. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J. 2002;19:209-16. [PMID: 11871363] CrossrefMedlineGoogle Scholar14. Casaburi R, Mahler DA, Jones PW, Wanner A, San PG, ZuWallack RL, et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J. 2002;19:217-24. [PMID: 11866001] CrossrefMedlineGoogle Scholar15. Oostenbrink JB, Rutten-van Mölken MP, Al MJ, Van Noord JA, Vincken W. One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease. Eur Respir J. 2004;23:241-9. [PMID: 14979498] CrossrefMedlineGoogle Scholar16. Campbell S. For COPD a combination of ipratropium bromide and albuterol sulfate is more effective than albuterol base. Arch Intern Med. 1999;159:156-60. [PMID: 9927098] CrossrefMedlineGoogle Scholar17. Chagnon I, Bounameaux H, Aujesky D, Roy PM, Gourdier AL, Cornuz J, et al. Comparison of two clinical prediction rules and implicit assessment among patients with suspected pulmonary embolism. Am J Med. 2002;113:269-75. [PMID: 12361811] CrossrefMedlineGoogle Scholar18. Annema JT, Versteegh MI, Veseliç M, Welker L, Mauad T, Sont JK, et al. Endoscopic ultrasound added to mediastinoscopy for preoperative staging of patients with lung cancer. JAMA. 2005;294:931-6. [PMID: 16118383] CrossrefMedlineGoogle Scholar19. Raghu G, Johnson WC, Lockhart D, Mageto Y. Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study. Am J Respir Crit Care Med. 1999;159:1061-9. [PMID: 10194146] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From Providence Portland Medical Center and the Oregon Clinic, Portland, Oregon.Disclosures: None disclosed.Corresponding Author: John E. Heffner, MD, Providence Portland Medical Center and the Oregon Clinic, 5050 NE Hoyt Street, Suite 540, Portland, OR 97213; e-mail, [email protected]com. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 21 November 2006Volume 145, Issue 10Page: 765-773KeywordsAsthmaComputed axial tomographyHospitalizationsInterstitial lung diseasesLung and intrathoracic tumorsLymph nodesPneumoniaTreatment guidelinesUltrasound imaging ePublished: 21 November 2006 Issue Published: 21 November 2006 CopyrightCopyright © 2006 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...